- Home
- LTH vs INM Comparison
LTH vs INM Comparison
Compare LTH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTH
- INM
- Stock Information
- Founded
- LTH 1992
- INM 1981
- Country
- LTH United States
- INM Canada
- Employees
- LTH N/A
- INM N/A
- Industry
- LTH Hotels/Resorts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LTH Consumer Discretionary
- INM Health Care
- Exchange
- LTH Nasdaq
- INM Nasdaq
- Market Cap
- LTH N/A
- INM 3.2M
- IPO Year
- LTH 2021
- INM N/A
- Fundamental
- Price
- LTH $31.65
- INM $2.98
- Analyst Decision
- LTH Buy
- INM
- Analyst Count
- LTH 12
- INM 0
- Target Price
- LTH $33.21
- INM N/A
- AVG Volume (30 Days)
- LTH 2.0M
- INM 54.4K
- Earning Date
- LTH 05-08-2025
- INM 05-13-2025
- Dividend Yield
- LTH N/A
- INM N/A
- EPS Growth
- LTH 100.00
- INM N/A
- EPS
- LTH 0.74
- INM N/A
- Revenue
- LTH $2,620,995,000.00
- INM $4,832,013.00
- Revenue This Year
- LTH $14.12
- INM N/A
- Revenue Next Year
- LTH $11.10
- INM N/A
- P/E Ratio
- LTH $42.20
- INM N/A
- Revenue Growth
- LTH 18.24
- INM N/A
- 52 Week Low
- LTH $12.34
- INM $1.72
- 52 Week High
- LTH $33.64
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- LTH 55.88
- INM 58.03
- Support Level
- LTH $30.41
- INM $2.85
- Resistance Level
- LTH $31.87
- INM $3.10
- Average True Range (ATR)
- LTH 1.38
- INM 0.25
- MACD
- LTH 0.10
- INM 0.06
- Stochastic Oscillator
- LTH 87.80
- INM 78.44
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.